Research progress regarding the role of long non‑coding RNAs in osteosarcoma (Review)
- Yanli Zhang
- Yanchuan Pu
- Jin Wang
- Zicai Li
- Hulin Wang
Affiliations: Department of Orthopedics, Wuwei People's Hospital, Wuwei, Gansu 733000, P.R. China
- Published online on: July 3, 2020 https://doi.org/10.3892/ol.2020.11807
Copyright: © Zhang
et al. This is an open access article distributed under the
terms of Creative
Commons Attribution License.
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Osteosarcoma is a malignant tumor that occurs in children and adolescents. Although treatments for osteosarcoma have improved, the likelihood of survival remains low for most patients with metastasis and recurrence. Elucidating the mechanism underlying the development of osteosarcoma and chemotherapy resistance will be important to improve diagnosis and treatment. Long non‑coding RNAs (lncRNAs), which are longer than 200 nucleotides in length and do not encode for proteins, have been shown to play a regulatory role in the occurrence and development of osteosarcoma, and are expected to serve as biomarkers and molecular targets. This review discusses the progress in the study of the role of lncRNAs in osteosarcoma, and highlights the recent developments in this field.